A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.
PHASE3CompletedINTERVENTIONAL
Enrollment
650
Participants
Timeline
Start Date
October 31, 2000
Study Completion Date
February 28, 2003
Conditions
Chronic Pain
Interventions
DRUG
tramadol ER
Trial Locations (1)
32605
Gainesville Clinical Research Center, Gainesville
All Listed Sponsors
lead
Bausch Health Americas, Inc.
INDUSTRY
NCT00347685 - A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain. | Biotech Hunter | Biotech Hunter